New Zealand based Douglas Pharmaceuticals Ltd is pleased to announce that a majority of patients with Treatment Resistant Depression experienced rapid relief of their symptoms when treated with R-107 (extended-release oral dose of ketamine) in a Phase 2 study
The Ministry of Health has confirmed there is sufficient supply of the Pfizer vaccine for district health boards to deliver more than half a million vaccinations as planned over the next five weeks
The increase of vaccine hesitancy caused by misinformation about the safety of the COVID vaccine is frustrating, and needs to stop, says Dr Bryan Betty, medical director at The Royal New Zealand College of General Practitioners
A study whose lead author is a Te Herenga Waka—Victoria University of Wellington epidemiologist has found the Pfizer-BioNTech COVID-19 vaccine used in New Zealand is not associated with a condition that affects the blood known as idiopathic thrombocytopenic purpura (ITP) and other clotting and bleeding events
Source
Media release from Te Herenga Waka - Victoria University of Wellington
Pfizer has scheduled delivery of an estimated 1 million doses of vaccine to New Zealand during July, COVID-19 Response Minister Chris Hipkins said today
Source
Media release from COVID-19 Response Minister Chris Hipkins
Pharmacy website platform Storbie is teaming up with Pharmacy Alliance to help independent community pharmacy members offer a modern, digital website experience to their communities
Four pharmacy students have today been awarded the Hiwinui Heke Māori Pharmacy Student Scholarship 2020, each receiving the prestige of joining the Hiwinui Heke scholarship alumni
High school students facing housing deprivation have double the rates of depression and suicide risk, according to a large-scale study based on the Youth2000 surveys co-led by Te Herenga Waka—Victoria University of Wellington and the University of Auckland
Source
Media release from Te Herenga Waka - Victoria University of Wellington
Academic pharmacist Nataly Martini provides key information on Helicobacter pylori pathophysiology, diagnosis and evidence-based treatment strategies to enhance patient outcomes